Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1251567

Wynnefield Capital Inc

Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$145.4M
Reported positions
8
Top holdings a year, 3 yrs
-6.0%
Assets under management
$184.5M

Wynnefield Capital Inc is a hedge fund that reported 8 positions worth $145.4M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Natures Sunshine Prods Inc (NATR, 37.1%), Cadre Hldgs Inc (CDRE, 23.6%), Lifecore Biomedical Inc (LNDC, 17.0%). A portfolio copying its top holdings returned -6.0% a year over the last 3 years, against 22.3% for the S&P 500.

Wynnefield Capital Inc holdings all 8 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Wynnefield Capital Inc 13F holdings
Stock% of 13F valueShare changeReported value
NATRNatures Sunshine Prods Inc37.1%+0.0%$53.9M
CDRECadre Hldgs Inc23.6%+4.8%$34.4M
LNDCLifecore Biomedical Inc17.0%+0.0%$24.7M
DLHCDlh Hldgs Corp13.3%+0.0%$19.3M
AEMAgnico Eagle Mines Ltd3.7%+0.0%$5.4M
QRHCQuest Resource Hldg Corp2.4%+0.0%$3.4M
TPCSTechprecision Corp1.6%+0.0%$2.3M
SILGlobal X Fds1.3%+0.0%$1.9M

What Wynnefield Capital Inc bought and sold in Q2 2026, against Q1 2026.

New positions

No new positions among the largest holdings.

Added to

No position grew by more than 5%.

Reduced

No position shrank by more than 5%.

Sold out

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
-18.4% /yr
S&P 500 +11.7%
3 years
-6.0% /yr
S&P 500 +22.3%
5 years
-1.4% /yr
S&P 500 +10.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$145.4M8
Q1 2026$147.5M9
Q4 2025$177.8M12
Q3 2025$166.4M15
Q2 2025$169.5M16
Q1 2025$158.0M16
Q4 2024$219.4M16
Q3 2024$224.7M17
Q2 2024$222.5M17
Q1 2024$251.7M23
Q4 2023$258.7M23
Q3 2023$217.9M21

Questions about Wynnefield Capital Inc's portfolio

What stocks does Wynnefield Capital Inc own?

Wynnefield Capital Inc's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 8 positions worth $145.4M. The largest are Natures Sunshine Prods Inc (NATR) at 37.1%, Cadre Hldgs Inc (CDRE) at 23.6%, Lifecore Biomedical Inc (LNDC) at 17.0%, Dlh Hldgs Corp (DLHC) at 13.3% and Agnico Eagle Mines Ltd (AEM) at 3.7%.

What did Wynnefield Capital Inc buy last quarter?

Wynnefield Capital Inc opened no new positions and grew none by more than 5% among its largest holdings in Q2 2026.

What did Wynnefield Capital Inc sell last quarter?

In Q2 2026, Wynnefield Capital Inc sold all of Nn Inc (NNBR), compared with its Q1 2026 filing.

How has Wynnefield Capital Inc's portfolio performed?

A portfolio copying Wynnefield Capital Inc's 20 largest 13F holdings each quarter, from the day each filing was public, returned -6.0% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: -18.4% against +11.7%. Over 5 years: -1.4% a year against +10.6%.

When is Wynnefield Capital Inc's next 13F filing due?

13F filings are due 45 days after each quarter ends. Wynnefield Capital Inc's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Wynnefield Capital Inc manage?

Wynnefield Capital Inc reported $184.5M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $145.4M.